Market News
Market news
-
News 2016 leaves pharma facing stormy waters
EP Vantage Releases its Annual Pharma and Medtech Sector Review Reports for 2016. -
News Innova Biosciences introduces Magnetic Conjugation Kit
New kit enables covalent conjugation of antibodies and proteins to magnetic particles. -
News Recipharm completes strategic acquisition in India
The acquired business is now known as Recipharm Pharmaservices Private Ltd. -
News Russian Government drive to increase domestic manufacturing fuelling growth at CPHI Russia
Distributors, API manufacturers, and machinery providers seeing high demand across Russia and CIS. -
News Companies harness AI power to improve medication adherence
Unique sensor technology tracks inhalation profiles and technique. -
News Sartorius and EMBL join forces to offer advanced training and science education
Sartorius is offering its expertise to enhance scientific education and practice. -
News Vectura achieves £9 million royalty cap from GSK Ellipta products
Company achieves the £9 million calendar year royalty cap on net sales of Ellipta products a year earlier than previously guided. -
News Catalent completes Accucaps acquisition
Expands softgel development and manufacturing capabilities and capacity. -
News FDA accepts BLA for Mylan and Biocon's proposed biosimilar pegfilgrastim for review
The proposed biosimilar to Neulasta is used to reduce the duration of neutropenia and the incidence of fever associated with neutropenia in adult patients treated with chemotherapy in certain types of cancer. -
News SGS expands elemental impurity testing services at its laboratory in Villeneuve-la-Garenne, France
Investment in a inductively coupled plasma mass spectrometry system is a move to address the updated ICH Q3D regulatory guidelines on elemental impurities. -
News Pharmapack Europe 2017 highlights new developments in pharma packaging and drug delivery
Trends include ‘human factor’ principles, with ‘individualised packaging and serialisation’ as the integral solutions of the future. -
News Generic and Biosimilar Manufacturers launch new brand and campaign
Generic Pharmaceutical Association becomes Association for Accessible Medicines. -
News Reig Jofre launches first dietary supplement for female androgenetic alopecia
Complidermol 5α PLUS tackles not only the known hormonal factor, but also the oxidative and inflammatory factors, new pathophysiological factors identified as causes of this condition. -
News Quotient Clinical acquires CDMO from CRL
Acquisition paves the way for Quotient to replicate its Translational Pharmaceutics platform in America. -
News Scottish CMO opens US office
Symbiosis Pharma now able to offer East and West Coast clients small-scale aseptic manufacturing capabilities to support clinical trials. -
News Hikma's exclusive licensing agreement with Orion for its new Easyhaler product in MENA
Easyhaler is a dry powder inhaler for the treatment of asthma and COPD. -
News Top pharmacovigilance trend in 2017
The Expanding role of pharmacovigilance in rapidly changing regulatory and commercial climates. -
News Ferring backs Foresee's SIF platform for controlled-release formulations
Foresee technology can help to develop stable, formulated peptides in solution for controlled-release therapy for 3- and 6-month durations of action after a single injection. -
News Pharma exhibitors at CPHI South East Asia use event to expand sales regionally
Favourable macro trends will be reflected at CPHI South East Asia where domestic manufacturers are increasingly attending the event, with a view to opening up sales in international markets. -
News ChinaSavvy lands $1.3 million engineering contract to supply components for high-tech storage systems
The initial US$1.3 million order is to supply components for ultra low temperature robotic storage systems in the US to major pharmaceutical companies. -
News I Holland launches innovative tool coating PharmaCote ECxtra
PharmaCote ECxtra has been developed to stop the issues encountered by hard chrome, but still provide a coating that provides excellent tooling protection. -
News Appeals Court grants stay of permanent injunction for Praluent during appeals process
Praluent continues to be available to patients in the US. -
News Austrian Centre of Industrial Biotechnology and GE Healthcare establish a cell line engineering collaboration
Partnership to explore and identify new tools and methods to modify and optimize the CHO cell line performance. -
News Integrated DNA Technologies acquires oligo manufacturing business of GeneWorks
IDT expands its capacity for direct sales of genomic products in Asia-Pacific region. -
News New OTC product with unique technology to help allergy sufferers
GSK launches Flonase Sensimist allergy relief nationwide. -
News Lilly's Trulicity label updated to include use in combination with basal insulin for adults with type 2 diabetes
Trulicity is a once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist injectable prescription medicine. -
News Dr Reddy's expands commercial operations in Europe
Company to introduce its portfolio of generics in France. -
News Pharmapack Europe Award Winners 2017 – 20 years of innovation
Vial injector, pharma compliance pack, smart packaging and autoinjector for prefilled syringes named best innovations in 2017. -
News TTP Labtech partners with Genedata to provide out-of-the-box data analysis for high throughput screening
The partnership will integrate Genedata Screener software with TTP Labtech’s acumen Cellista and mirrorball to improve screening data management. -
News Smart Pill Bottle receives the Good Design Award 2016
Personal medical device leveraging "Internet of Things" technologies to address medication adherence. -
News STA Pharma expands R&D team at is Changzhou site
By the end of 2017, company plans to increase to 230 process chemists and 70 analytical chemists. -
News Frutarom Health increases phytopharmaceutical capacity
Acquisition of Extrakt Chemie and site investments in people, equipment, manufacturing buildings and new offices increases company's position in Germany. -
News Medical marijuana market size to reach USD 55.8 billion by 2025
The growing number of states and countries getting approval for using marijuana in therapeutic applications is a crucial factor driving the demand over the coming few years. -
News The Safelia autoinjector wins the ‘Exhibitor Innovation’ Award at Pharmapack
A team of industry experts reward Nemera’s autoinjector with a Pharmapack Award as best innovation product. -
News FDA approves BMS's Opdivo for bladder cancer
Opdivo has now been approved in six tumour types in just over 2 years. -
News Reach Separations celebrates 5th birthday with record year
The company’s growth has been driven by export, with a three-fold increase in activity outside of the UK during 2016, -
News Leukocare signs up to become Rentschler's specialized tech partner and formulation developer
Rentschler will become the first and only CDMO to have access to Leukocare's patented SPS formulation technologies. -
News KBI Biopharma expands services, including cell therapy manufacturing, through acquisition
Acquisition provides fully equipped facilities for the development and manufacture of clinical stage cellular therapy products, including three ISO7 cGMP manufacturing suites, extensive flow cytometry and analytical infrastructure. -
News Aralez Pharmaceuticals unveils new office in Ireland
The Dublin offices are the company's first permanent business premises outside of North America. -
News EPO upholds decision regarding Sprycel
Patent found to be invalid. -
News Allergan successfully completes LifeCell acquisition
Acquisition creates world-class aesthetic and regenerative medicine business in plastic surgery. -
News Biogen completes separation of global hemophilia business, Bioverativ
Bioverativ common stock to be traded on the NASDAQ global select market. -
News Sanofi's Xyzal Allergy 24HR approved for OTC use in the US
Xyzal is an oral antihistamine with a proven 24-hour effect. -
News Mylan wins US District Court ruling related to Copaxone 40 mg/mL patents
Patents in question invalidated based on obviousness. -
News IBA Molecular acquires Mallinckrodt nuclear imaging to create world-class radiopharmaceuticals group
The enlarged business will comprise 21 manufacturing centres and commercial operations across 60 countries. -
News Pharmaceutical packaging market expected to reach $104,882 million by 2022
Manufacturing projects in eco-friendly and biodegradable packaging, which is expected to surge in near future. -
News Big data on way to enabling 'zero defect' glass tubing
New perfeXion system, which generates around 100,000 data tags/min, makes an important contribution to quality assurance for downstream post-processing steps at the beginning of the value chain. -
News Rapid emergence of MENA biologics industry sees first ever Biopharma Conference and new venue at CPHI Istanbul 2017
Developments in local manufacturing, regulatory strategies, market entry and harmonisation to be debated by MENA leaders and Government. -
News Mobius Power MIX mixing systems bring ease of use to single use
Effectively handles difficult-to-mix pharmaceutical ingredients. -
News Sunovion’s Latuda receives FDA approval to treat adolescents with schizophrenia
First treatment approved in 5 years for adolescents aged 13-17 years with schizophrenia. -
News J&J to acquire Acelion for $30 B with spin-out of new R&D company
Actelion R&D unit to spin out into standalone company based and listed in Switzerland. -
News Knopp Biosciences receives key patent directed to ion channel activators for brain disorders
Issued claims are directed to a series of orally available small molecules and their use in treating epilepsy, neuropathic pain, and other neurological disorders. -
News FDA approves 72 mcg dose of Linzess for adults with chronic idiopathic constipation
New dosage strength expected to be available in first quarter of 2017. -
News Endo to axe 90 full-time positions as part of organizational review
Company expects to invest cost savings in its branded and generics business segments. -
News Axim Biotech enters IBS clinical trial for CanChew CBD chewing gum
Clinical trial is the first of its kind to treat IBS symptoms by cannabinoid-containing chewing gum. -
News Clinerion introduces new services for market access
Disease prevalence can be monitored with a precision never before possible. -
News Intrexon to acquire GenVec to expand industry-leading gene delivery platform
GenVec's AdenoVerse to be integrated into Intrexon's proprietary synthetic biology platform. -
News SGS increases extractables and leachables identification capabilities at its Fairfield, NJ laboratory
Investments include an LC-MS/MS, and GC-MS with head-space capability, for improved and rapid identification of trace unknown extractable compounds. -
News Vetter starts operations in its center for visual inspection and logistics
Site enlargement enables increased capacity for state-of-the-art quality control and storage. -
News Enteris and Sanofi to develop oral therapeutic for type 2 diabetes
Feasibility study to examine three different oral formulations engineered with Enteris’ Peptelligence platform. -
News Enamine expands collaboration with Europe’s largest biopharmaceutical company
Extends multi-year agreement in drug discovery with focus on cardiovascular and central nervous system disorders, immunology, infectious diseases and oncology. -
News Irvine Scientific introduces PRIME-XV T cell CDM for immunotherapy applications
The first chemically-defined, animal component-free, cell culture medium for T cells. -
News Endo agreement to resolve FTE investigation and litigation
No admission of wrongdoing, No monetary payment by Endo. -
News BMS, Ono Pharma and Merck resolve PD-1 antibody patent litigation
Merck to pay BMS and Ono royalties on global sales of Keytruda through 2026, and lump-sum payment of $625 million. -
News Mylan acquires Cold-EEZE brand to further expand OTC business
Cold-EEZE will become Mylan's largest US OTC brand franchise. -
News Lilly to acquire CoLucid for $960 million
Deal will enhance Lilly's existing pain management portfolio for migraine and adds potential near-term launch to its late-stage pipeline. -
News Hikma receives FDA approval for generic equivalent to Xyrem
Company's subsidiary currently involved in patent litigation concerning this product. -
News Merck opens production facility exclusively for meglumine
Regulatory compliant, FDA-audited facility based in Mollet des Vallès, Spain. -
News Biogen agrees to pay Forward Pharma $1.25 billion
The settlement and license agreement will strengthen Biogen's IP for leading oral therapy for multiple sclerosis. -
News Suliqua approved in the EU for the treatment of adults with type 2 diabetes
Suliqua will be delivered in two pre-filled SoloSTAR pens, providing different dosing options that may help answer individual market and patient insulin needs. -
News MicroJect Reactor technology to take centre stage in new partnership
leon nanodrugs' MJR technology offers reformulation options that address API solubility issues. -
News A-Skin secures patent for groundbreaking skin engineering therapy
WHF therapy can be directly applied on a wound to stimulate the natural human wound healing process. -
News Ipsen to acquire oncology assets from Merrimack Pharmaceuticals
Transaction includes US commercialization rights for Onivyde for metastatic pancreatic cancer in adult patients. -
News Tesaro receives CRL for rolapitant IV from FDA
No concerns raised by FDA related to the rolapitant IV efficacy or safety profile and additional clinical studies are not required. -
News New-generation mealtime insulin approved in Europe
Novo Nordisk to launch Fiasp in first half of 2017. -
News VivaGel BV granted QIDP and Fast Track designation by FDA
Product receives designations for both the BV treatment and prevention indications. -
News Sartorius Stedim Biotech opens a new validation service laboratory at its Shanghai site
Comprehensive validation services for the Chinese market. -
News Merck Licenses four oncology R&D programs from Vertex
All programs (two promising clinical-stage programs targeting DNA damage and repair, and two novel pre-clinical programs) have first-in-class and best-in-class potential. -
News US Court of Appeals rules in Lilly's favour on Alimta vitamin regimen patent
If the patent is ultimately upheld through all remaining challenges, Alimta would maintain US exclusivity until May 2022. -
News Lilly and Merck expand immuno-oncology collaboration
New study to evaluate combination of Lartruvo and Keytruda. -
News Stellar Biotechnologies advances strategic plan to secure key production region
Company aims to increase production capacity to supply multiple commercial-scale therapeutic vaccines under development. -
News Piqur and Pierre Fabre announce partnership in dermato-oncology
Collaboration will give Pierre Fabre the option to enter into exclusive negotiations to license global rights for the program in selected skin cancer conditions. -
News Merck expands end-to-end biodevelopment centers
Expansionincludes the opening of two new process development centers in the US and China. -
News Pharma predictions for 2017: the good, the bad, and the Donald
Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities. -
News Innova Biosciences introduces the Conjugate Check&Go! Kit
Scientists can confirm, in one easy step, whether an antibody has been successfully conjugated. -
News Aurobino subsidiary to acquire Generis Farmaceutica
Generis is the most sold pharmaceutical brand in Portugal, and is the #2 generic group in Portugal. -
News Allergan obatins worldwide rights to microbiome GI development programs
Deal expands Allergan's innovative GI [ipeline with ABI-M201 and ABI-M301, preclinical compounds targeting Uucerative colitis and Crohn's disease, as well as future compounds for irritable bowel syndrome. -
News Takeda and PvP Biologics sign development agreement around novel therapeutic for celiac disease
KumaMax could provide hope celiac patients who try, but are unable to completely avoid gluten exposure in their diets, -
News Catalent to develop softgel capsules for JOT's leading orphan disease candidates
JOTROL is being developed to remedy resveratrol’s poor bioavailability and dose limiting gastrointestinal side effects. -
News Cardinal Health reaches $20 million settlement with West Virginia
Company collaborating with all participants in the pharma supply chain to tackle to the epidemic of prescription drug abuse. -
News Ariad to be acquired by Takeda for $5.2 billion
Ariad stockholders to receive $24.00 per share in cash. -
News Ascendia Pharmaceuticals awarded new patent on its ASD-002 program for acute coronary syndrome
A ready-to-use, stable and soluble, parenteral form of clopidogrel is feasible using the company's nanoemulsion platform technology. -
News Lilly to adjust organization and leadership structure
Christi Shaw hired to lead Bio-Medicines; Conterno to assume additional geographic responsibilities, including Lilly USA leadership; Zulueta to lead International business. -
News BMS and Janssen to collaborate to evaluate Opdivo in combination with Darzalex
Phase Ib/II studies to explore a novel immuno-oncology combination in hematological and solid tumours with high unmet medical need. -
News Noxxon Pharma licenses and assigns preclinical Spiegelmer programs to Aptarion
Noxxon continues transition to clinical oncology company. -
News Lonza concludes divestment of peptides business and operations in Braine-l’Alleud, Belgium
PolyPeptide Laboratories' acquisition brings immediate access to additional large-scale capacity in synthesis, purification and isolation of peptides. -
News RedHill Biopharma announces exclusive US co-promotion agreement with Concordia for GI drug Donnatal
Concordia will continue to be responsible for the manufacturing and supply of Donnatal in all territories. -
News Directorate change at Shire
Appointment of Ian Clark as Non-Executive Director. -
News SP Scientific launches new PennTech website
Website allows visitors to simply and quickly locate pertinent information. -
News Ensuring robust lyophilization scale-up
Presentation provides new data regarding the mechanism of the ControLyo Technology. -
News Sanofi Pasteur and MSD end joint vaccines business in Europe
Each company will separately pursue their own vaccine strategies in Europe. -
News Provectus Biopharmaceuticals terminates Peter Culpepper as Interim CEO and COO
Investigation reveals improper expense reimbursements. -
News Pfizer completes acquisition of small molecule anti-infective business from AstraZeneca
Agreement includes the commercialization and development rights to the newly approved EU drug Zavicefta (ceftazidime-avibactam). -
News Recursion receives industry awards for drug discovery platform
Computationally intelligent drug discovery platform receives two Fierce Innovation awards for Biotech Innovation and Best New Product. -
News Vectura and Mundipharma sign global development programme
Development and licence agreement is for pMDI inhaled triple therapy (VR2076) for asthma and COPD. -
News New pill available on the NHS for patients suffering with psoriatic arthritis
Oral Otezla receives positive NICE recommendation for adults with psoriatic arthritis. -
News Leadership transition for Impax Laboratories
Mr Wilkinson no longer President and CEO and a member of the Board. -
News Baxter to expand portfolio of essential generic injectable medicines with acquisition of Claris Injectables
Acquisition adds global portfolio of sterile injectables, robust pipeline, and manufacturing capabilities. -
News Licensing agreement signed for the launch of Utibron/Seebri in the US
Novartis and Sunovion Pharmaceuticals strike agreement for three COPD treatments. -
News Giovanni Caforio named chairman of BMS’s Board of Directors
Caforio will succeed Lamberto Andreotti effective 2 May 2017. -
News Allergan to acquire Acelity's LifeCell Corporation for $2.9 billion
Key products include Alloderm and Stratticem tissue matrices commonly used in breast reconstruction and abdominal wall surgeries. -
News Aurinia and Lonza enter long-term manufacturing collaboration for clinical supply of voclosporin
The agreement also provides an option to have Lonza exclusively supply API for up to 20 years. -
News Novartis bolsters ophthalmology pipeline through acquisition of Encore Vision
Acquisition of Encore Vision, to add first-in-class disease modifying topical treatment for presbyopia patients to the Novartis ophthalmology pipeline in an area of high unmet medical need and high prevalence -
News Sterling and TPI strike codeine agreement
Agreement is the first step in TPI Enterprises’ plan to expand its presence in the UK market. -
News FDA approves removal of boxed warning regarding serious neuropsychiatric events from Chantix labeling
Labeling revisions also include updates to corresponding warning and addition of clinical data on superior efficacy of Chantix compared with bupropion or nicotine patch. -
News Sanner IDP-Process – individual packaging in six steps
Pharmapack 2017: focus on tailor-made packaging. solutions -
News Boehringer Ingelheim and Lilly welcome new recommendation for Jardiance tablets in updated ADA's 2017 Standards
Guidelines include new recommendation to consider the use of Jardiance in people with type 2 diabetes and established cardiovascular disease to reduce the risk of cardiovascular death. -
News Mylan launches the first generic for EpiPen Auto-Injector as an authorized generic
Authorized generic offered at more than 50% below wholesale acquisition cost of EpiPen auto-injector. -
News Merck's Idenix Pharmaceuticals awarded $2.54 billion for infringement of a hepatitis C drug patent
In its decision, the jury also concluded that Gilead “willfully” infringed upon the patent.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance